Cancer Vaccines & Data Center Drama

The podcast kicks off with a discussion on the significance of interest rates for the economy and investors. Jim emphasizes that interest rates serve as a lubricant for the economy, affecting how much can be done with money. Despite recent increases, current rates remain below historical peaks of the 70s, 80s, and 90s, and the prior era of 'free money' led to bad ideas and risky behaviors. Jim and Lou analyze how governments, particularly the US and Canada, manage their debt, with concerns about the sustainability of current debt levels, especially given the large scale of US federal debt (~$40 trillion). They discuss the bond market's role in signaling economic health and the impact of government actions like issuing short-term debt to buy down long-term rates. The overall message is that rising interest rates increase borrowing costs and complicate fiscal management but are part of a broader, natural market process.

The hosts highlight Moderna’s promising phase three trial for a cancer vaccine, which could be transformative for humanity. Lou and Jim recognize the potential while also cautioning that many biotech breakthroughs, especially IPOs, tend to underperform initially. Jim shares his own experience with Moderna, noting its recent stock decline despite strong fundamentals, and suggests diversifying exposure via biotech ETFs. The discussion touches on whether AI advancements are leading to a new era in healthcare, with cautious optimism that incremental progress continues, though AI still primarily mimics language skills rather than deep biological understanding.

The podcast discusses recent negative public opinion and political pushback against data center expansion, which is crucial for AI development. Lou points out that the industry has a messaging problem, often dismissing local concerns and presenting AI infrastructure growth as inevitable or beneficial. Jim jokes about space-based data centers as a potential solution. They emphasize the disconnect between Silicon Valley’s enthusiasm and flyover country’s indifference, highlighting the need for better communication and community engagement to avoid worsening political tension.

The hosts analyze various stocks, providing insights and valuation perspectives. Jim discusses Peloton, noting its improved cash flow and balance sheet after restructuring, trading at a low valuation relative to free cash flow, making it an attractive turnaround story. Lou focuses on Union Pacific, considering the potential impact of a proposed merger with Norfolk Southern and the long timeline involved. Jim shares his skepticism about Disney, criticizing its overextension and valuation multiple, and amusingly suggests Disney could benefit from being acquired by Apple. Lou expresses interest in Union Pacific’s strategic move. The segment closes with a humorous debate on Tesla’s valuation, with Jim setting a high price threshold for buying and Lou offering a more optimistic view, reflecting differing investment philosophies.